Welcome to LookChem.com Sign In|Join Free

CAS

  • or

17238-05-0

Post Buying Request

17238-05-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

17238-05-0 Usage

Chemical Properties

Light Beige Needles

Uses

Different sources of media describe the Uses of 17238-05-0 differently. You can refer to the following data:
1. A metabolite of Daidzein.
2. Daidzein is an isoflavonoid phytoestrogenic compound found in soybeans, pea pods, clover, kudzu, and other legumes. Dihydrodaidzein is an active, estrogenic metabolite of daidzein. It has vasodilatory action on rat isolated aortic rings at 1 μg/ml. It stimulates the estrogen receptor-dependent growth of breast cancer MCF-7 cells at micromolar concentrations. Dihydrodaidzein is produced by the metabolism of daidzein in colonic bacteria and may be further metabolized to various bioactive compounds, including equol .

Definition

ChEBI: A hydroxyisoflavanone that is isoflavanone carrying two hydroxy substituents located at positions 4' and 7.

Biological Activity

dihydrodaidzein, an active, estrogenic metabolite of daidzein in colonic bacteria, probably is further metabolized to various bioactive compounds including equol. as an estrogen receptor agonist, dihydrodaidzein, at micromolar concentrations, activates the estrogen receptor-dependent growth of breast cancer cells. daidzein, an isoflavonoid phytoestrogenic compound, is found in soybeans, clover, kudzu, and other legumes.

in vitro

prostatic fluid and plasma concentrations of dihydrodaidzein were sufficient to block the growth of benign human prostatic epithelial cells (prec). dihydrodaidzein showed a significant inhibitory effect on the growth of prostate cancer cell line lncap. additionally, dihydrodaidzein slightly triggered the apoptosis of prec. in addition to affecting apoptosis, dihydrodaidzein decreased proliferation, which was associated with the changes in cell cycle distribution and caspase 3 activation [1].

in vivo

male c57b1/6 wild type mice were administered orally with dihydrodaidzein at a dose of 25 mg/kg/day for 4 weeks. compared to the control groups, the neointima of mice treated with dihydrodaidzein was thickened. in dihydrodaidzein-treated mice, the intimal thickness in the non-injured right iliac artery was not altered. moreover, neointimal proliferation was selectively blocked by dihydrodaidzein via suppressing the migration and proliferation of vascular smooth muscle cell and dampening the endothelial apoptosis [2].

references

[1]. hedlund, t., bokhoven, a., johannes, w., nordeen, s., & ogden, l. prostatic fluid concentrations of isoflavonoids in soy consumers are sufficient to inhibit growth of benign and malignant prostatic epithelial cells in vitro. the prostate. 2006; 66(5): 557-566. [2]. shen, j., white, m., husband, a., hambly, b., & bao, s. phytoestrogen derivatives differentially inhibit arterial neointimal proliferation in a mouse model. european journal of pharmacology. 2006; 548(1-3): 123-128.

Check Digit Verification of cas no

The CAS Registry Mumber 17238-05-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,2,3 and 8 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 17238-05:
(7*1)+(6*7)+(5*2)+(4*3)+(3*8)+(2*0)+(1*5)=100
100 % 10 = 0
So 17238-05-0 is a valid CAS Registry Number.
InChI:InChI=1/C15H12O4/c16-10-3-1-9(2-4-10)13-8-19-14-7-11(17)5-6-12(14)15(13)18/h1-7,13,16-17H,8H2

17238-05-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (D4239)  Dihydrodaidzein  >97.0%(HPLC)

  • 17238-05-0

  • 25mg

  • 2,150.00CNY

  • Detail

17238-05-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name dihydrodaidzein

1.2 Other means of identification

Product number -
Other names dihydrodaizein

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:17238-05-0 SDS

17238-05-0Related news

Enhanced biosynthesis of Dihydrodaidzein (cas 17238-05-0) and dihydrogenistein by a newly isolated bovine rumen anaerobic bacterium08/24/2019

A rod-shaped and Gram-positive anaerobic bacterium, named Niu-O16, which was isolated from bovine rumen contents, was found to be capable of anaerobically converting isoflavones daidzein and genistein to dihydrodaidzein (DHD) and dihydrogenistein (DHG), respectively. The metabolites DHD and DHG ...detailed

17238-05-0Relevant articles and documents

Biotransformation of daidzein to equol by crude enzyme from Asaccharobacter celatus AHU1763 required an anaerobic environment

Thawornkuno, Charin,Tanaka, Michiko,Sone, Teruo,Asano, Kozo

, p. 1435 - 1438 (2009)

Asaccharobacter celatus AHU1763 is a Gram-positive, obligate anaerobic, non-spore forming, rod-shaped bacteria that was successfully isolated from rat cecal content. Daizein was converted to equol via dihydrodaidzein by this bacterium. A crude enzyme that converted daidzein to dihydrodaidzein was detected mainly in the culture supernatant. The ability of this enzyme dropped after the culture supernatant was exposed to a normal atmospheric environment for even 5 min. Furthermore, the enzyme responsible for changing dihydrodaidzein to equol was detected mainly in the cell debris, which required anaerobic conditions for its activity.

PRODUCTION METHOD OF OPTICALLY ACTIVE 3-SUBSTITUTED CHROMAN-4-OL COMPOUND

-

Paragraph 0076-0078, (2017/01/02)

PROBLEM TO BE SOLVED: To provide a versatile and highly productive production method of an optically active 3-substituted chroman-4-ol compound. SOLUTION: A production method of an optically active 3-substituted chroman-4-ol compound includes performing a reduction reaction of a 3-substituted chroman-4-one compound in the presence of a metal complex represented by formula (I) (in formula (I), M represents a group 8 transition metal or the like, each of R1 and R2 independently represents a hydrogen atom, a 1-6C alkyl group or the like, R3 represents a 1-6C alkyl group or the like, R4 represents a 1-6C alkyl group or the like, Ar represents benzene bonded with M via a π bond or the like, and X represents a carbonyloxy group or the like). COPYRIGHT: (C)2015,JPOandINPIT

ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER

-

Page/Page column 35; 37, (2012/05/20)

Provided herein is a pharmaceutical composition comprising at least one isoflavonoid. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 17238-05-0